Business Description
Damloran Pharmaceutical
ISIN : IRO1DAML0006
Description
Damloran Pharmaceutical manufactures and markets livestock and poultry pharmaceuticals. The Company offers animal health products to protect and improve health and hygiene of society to treat and to enhance the quality of animals' life.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Piotroski F-Score | N/A/9 | |||||
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
6-1 Month Momentum % | 28.28 | |||||
12-1 Month Momentum % | 17.07 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 7.18 | |||||
Forward Dividend Yield % | 7.18 | |||||
5-Year Yield-on-Cost % | 7.18 |
Profitability Rank
4/10
| Name | Current | Vs Industry | Vs History |
|---|
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | N/A |
N/A
|
N/A
| |||
PE Ratio without NRI | N/A |
N/A
|
N/A
|
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Damloran Pharmaceutical Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil IRR) | |||
| EPS (TTM) (IRR) | - | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | 0.41 | ||
| 3-Year Sortino Ratio | 0.72 | ||
| Volatility % | 11.92 | ||
| 14-Day RSI | - | ||
| 14-Day ATR (IRR) | 346.428571 | ||
| 20-Day SMA (IRR) | - | ||
| 12-1 Month Momentum % | 17.07 | ||
| 52-Week Range (IRR) | 7510 - 17690 | ||
| Shares Outstanding (Mil) |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Damloran Pharmaceutical Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Damloran Pharmaceutical Stock Events
| Event | Date | Price (IRR) | ||
|---|---|---|---|---|
| No Event Data | ||||
Damloran Pharmaceutical Frequently Asked Questions
What is Damloran Pharmaceutical(XTEH:DAML1)'s stock price today?
The current price of XTEH:DAML1 is IRR10100.00. The 52 week high of XTEH:DAML1 is IRR17690.00 and 52 week low is IRR7510.00.
When is next earnings date of Damloran Pharmaceutical(XTEH:DAML1)?
The next earnings date of Damloran Pharmaceutical(XTEH:DAML1) is .
Does Damloran Pharmaceutical(XTEH:DAML1) pay dividends? If so, how much?
The Dividend Yield %  of Damloran Pharmaceutical(XTEH:DAML1) is 7.18% (As of Today), Highest Dividend Payout Ratio of Damloran Pharmaceutical(XTEH:DAML1) was 0. The lowest was 0. And the median was 0. The  Forward Dividend Yield % of Damloran Pharmaceutical(XTEH:DAML1) is 7.18%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Damloran Pharmaceutical
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers